Stockholm Corporate Finance in collaboration with Financial Hearings is pleased to invite you to the Öresund Investment Day
Date: Monday 22nd of September Place: Medicon Village, Hörsalen Scheeleveägen 2, Lund
The 17th edition of Öresund Investment Day glances past the last minute of the stock market movement and quarterly report, and focuses on the companies long-term development. During Öresundsdagen you will be able to listen to presentations by interesting companies in the Life Science and Foodsector.
The presentations are followed by a brief Q&A, Mattias Hägglund and Martin Parkhöj from Danske Markets are moderators.
08.00 Medicon Village Mats Leifland 08.20 *Lundbeck CEO Ulf Wiinberg 08:40 Medic Pen CEO Per Nilsson 09.00 Probi CEO Peter Nählstedt 09.20 Cloetta VP Communication and IR Jacob Broberg 09.40 Vigmed CEO Finn Ketler 10.00 Coffee 10.20 Midsona CEO Peter Åsberg 10.40 Hansa Medical CEO Emanuel Björne 11.00 Exini Diagnostics CEO Magnus Aurell 11.20 Enzymatica CEO Michael Edelborg Christenssen 11.40 Bioinvent CEO Michael Oredsson 12.00 Lunch 12.20 *Lidds CFO Lars-Åke Malmsten 12.40 Active Biotech CSO Helén Tuvesson 13.00 Saniona CEO Jørgen Drejer 13.20 Bonesupport CEO Lloyd Diamond 13.40 Coffee 14.00 Zealand Pharma CFO Mats Blom 14.20 Novo Zymes IR Thomas Steenbeck Bomhoff 14.40 Karolinska Development CEO Thorbjörn Bjerke 15.00 *Astra Zeneca IR Jens Lindberg 15.20 *Baxter (Gambro) CFO Sweden Ulrik Nilsson 15.40 Future Cities - Öresund Torbjörn Isaksson
Stockholm Corporate Finance is an independent, privately owned financial advisor offering services for professional advice in relation to capital, changes in ownership, acquisition, mergers and acquisitions (M & A) to publicly traded and private companies and their owners. Stockholm Corporate Finance is the Swedish partner in the global network of M & A Worldwide consisting of 40 M & A advisors and investment banks in 36 countries. Stockholm Corporate Finance is an investment firm which is under the supervision of FSA. www.stockholmcorp.se
For participation and more info: www.financialhearings.com
